Shantibhusan Senapati
Scientist-D
Department of Biotechnology
Institute of Life Sciences, Nalco Square
India
Biography
Academic Qualification Ph.D. (2005-10): Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, USA B.V.Sc. & A.H. (1996-2002): College of Veterinary Science and Animal Husbandry, OUAT, Odisha, India Academic and other Positions Scientist-D, Institute of Life Sciences, Bhubaneswar, India since September, 2015. Ramalingaswami Fellow Scientist, Institute of Life Sciences, Bhubaneswar, India April 2012 to September, 2015. Postdoctoral Researcher, Ohio State University, Comprehensive cancer center, Columbus, Ohio, USA, 2010-2012 Research Assistant, University of Nebraska Medical Center, Omaha, NE, USA, 2005-2010 Junior Veterinary Officer, Government Hospital, Kandhamala, Orissa, India 2003- 2005 Veterinary Extension Officer, Heifer Project International, Bhubaneswar, India 2002-2003 Academic Awards and Achievements Harris award in cancer research, UNMC, NE, USA 2010 Predoctoral students travel award to attain the AACR meeting 2009 (Denver, USA) Harris award in cancer research, UNMC, NE, USA 2009 Abstract selected for the oral presentation at the 2008 International Student Forum Student merit scholarship, B.V.Sc, O.U.A.T, India 1997
Research Interest
Cancer pathogenesis, Inflammation and cancer, Cancer Metastasis
Publications
-
Sarkar S, Jain S, Rai V, Sahoo DK, Raha S, Suklabaidya S, Senapati S, Rangnekar VM, Maiti IB, Dey N. Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells. Frontiers in plant science. 2015;6.
-
Jain S, Suklabaidya S, Das B, Raghav SK, Batra SK, Senapati S. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells. The Prostate. 2015 Jul 1;75(10):1020-33.
-
Barman PK, Mukherjee R, Prusty BK, Suklabaidya S, Senapati S, Ravindran B. Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice. Cell death & disease. 2016 May;7(5):e2224.
-
Suklabaidya S, Das B, Ali SA, Jain S, Swaminathan S, Mohanty AK, Panda SK, Dash P, Chakraborty S, Batra SK, Senapati S. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget. 2016 Jul 5;7(27):41825.
